Angiodynamics (ANGO) Gross Profit (2010 - 2026)

Angiodynamics' Gross Profit history runs 17 years deep, the most recent figure standing at $46.8 million for Q2 2026.

• Quarterly Gross Profit rose 10.79% year-over-year to $46.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $174.9 million (up 10.9% YoY) and the FY2026 annual result came in at $174.9 million, up 10.9% from the prior year.
• Gross Profit was $46.8 million for Q2 2026 at Angiodynamics, up from $41.5 million in the prior quarter.
• Across five years, Gross Profit topped out at $46.8 million in Q2 2026 and bottomed at $35.9 million in Q1 2024.
• A 5-year average of $41.5 million and a median of $41.0 million in 2023 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2024 — Gross Profit decreased 16.92% — and 2025, when it gained 13.98%.
• Angiodynamics' Gross Profit stood at $45.1 million in 2022, then slipped by 10.68% to $40.3 million in 2023, then declined by 0.88% to $39.9 million in 2024, then gained by 12.22% to $44.8 million in 2025, then advanced by 4.44% to $46.8 million in 2026.
• Business Quant data shows ANGO's Gross Profit at $46.8 million in Q2 2026, $41.5 million in Q1 2026, and $44.8 million in Q4 2025.